Skip to main content

Advertisement

Log in

Towards host-directed therapies for tuberculosis

  • Comment
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This article has been updated

Abstract

The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Change history

  • 04 August 2015

    The spelling of Voahangy Rasolofo's name has been corrected.

References

  1. Zumla, A., Nahid, P. & Cole, S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12, 388–404 (2013).

    Article  CAS  Google Scholar 

  2. Zumla, A. et al. Tuberculosis treatment and management — an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir. Med. 3, 220–234 (2015).

    Article  Google Scholar 

  3. Wallis, R. S. & Hafner, R. Advancing host-directed therapy for tuberculosis. Nat. Rev. Immunol. 15, 255–263 (2015).

    Article  CAS  Google Scholar 

  4. Bento, C. F., Empadinhas, N. & Mendes, V. Autophagy in the fight against tuberculosis. DNA Cell Biol. 34, 228–242 (2015).

    Article  CAS  Google Scholar 

  5. Stanley, S. A. et al. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 10, e1003946 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Alimuddin Zumla or Markus Maeurer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Supplementary information

Supplementary information S1 (table)

Interventions under investigation as host-directed therapies for tuberculosis (PDF 282 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zumla, A., Chakaya, J., Hoelscher, M. et al. Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov 14, 511–512 (2015). https://doi.org/10.1038/nrd4696

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4696

  • Springer Nature Limited

This article is cited by

Navigation